Maxcare Drugs Private Limited
About Maxcare Drugs Private Limited
Data last updated:
Maxcare Drugs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 December 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC166389. Its GSTIN is 08AAECM8980A1ZD (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ankita Gupta and Rajesh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 503 Indravani Apartment Nr. Mary Immculate School Nr. Dwarkeshdam L.M.Road Borivali, Mumbai, Maharashtra, India – 400103.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.57 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1,638 (net margin 0%) and EBITDA of ₹21,537 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 186% over three years.
As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Maxcare Drugs Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address503 Indravani Apartment Nr. Mary Immculate School Nr. Dwarkeshdam L.M.Road Borivali, Mumbai, Maharashtra, India – 400103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxcare Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxcare Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maxcare Drugs Private Limited, buy the company report.
Financials of Maxcare Drugs Private Limited
FY 2025 filings availableMaxcare Drugs Private Limited reported revenue of ₹47.57 Lakh (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 186% over three years, including 36% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,537 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,638 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxcare Drugs Private Limited, buy the company report.
Board of directors of Maxcare Drugs Private Limited
Maxcare Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankita Gupta Also directs: Urbanrepairs Private Limited | Director | 21 Dec 2006 | 19 Years 10 Months | Current |
| Rajesh Gupta Also directs: Dee Drugs Private Limited | Director | 21 Dec 2006 | 19 Years 10 Months | Current |
Auditor
Maxcare Drugs Private Limited is audited by AGARWAL RUWATIA AND ASSOCIATES LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL RUWATIA AND ASSOCIATES LLP | FY 2022 | 008850C |
Shareholding
The shareholding of Maxcare Drugs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxcare Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 May 2012 | 10357500 | Punjab National Bank | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Maxcare Drugs Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Civil suit | Filed against the company by Ms Alves Health Care Pvt. Ltd. | Disposed |
To see the full case history of Maxcare Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxcare Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxcare Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECM8980A1ZD | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxcare Drugs Private Limited, buy the company report.
Recent activity
Maxcare Drugs Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Manoj Kumar Jain ceased to be Director on 01 Oct 2011.
Frequently asked questions
Maxcare Drugs is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 December 2006 (20+ years old) and is registered under CIN U24239MH2006PTC166389.
Maxcare Drugs has 2 current directors:
- Ankita Gupta - Director
- Rajesh Gupta - Director
The latest financial statements of Maxcare Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxcare Drugs is 08AAECM8980A1ZD, registered in Rajasthan.
The CIN (Corporate Identification Number) of Maxcare Drugs is U24239MH2006PTC166389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxcare Drugs has 1 court case on record: 1 filed against it.
Maxcare Drugs was incorporated on 21 December 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Manoj Kumar Jain ceased to be Director on 01 Oct 2011. Mridul Jain ceased to be Director on 01 Oct 2011. Ankita Gupta was appointed as Director on 21 Dec 2006. Maxcare Drugs has 4 board changes on record in total.
The registered office of Maxcare Drugs is at 503 Indravani Apartment Nr. Mary Immculate School Nr. Dwarkeshdam L.M.Road Borivali, Mumbai, Maharashtra, India – 400103.
Maxcare Drugs operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
